by Chris Thurstone | Mar 18, 2016 | Marijuana, Research
The news from London-based GW Pharmaceuticals is worth celebrating: Epidiolex — purified, pharmacy-grade and nonintoxicating cannabidiol extracted from the cannabis plant — has both Orphan Drug Designation and Fast Track Designation from the U.S. Food and...
by Christine Tatum | Dec 24, 2015 | Marijuana, Research
Research of cannabidiol, a non-intoxicating component of the cannabis plant, has been made easier because of new regulations released this week by the Drug Enforcement Administration. The federal agency has waived certain registration requirements for researchers...
by Chris Thurstone | Feb 3, 2015 | Marijuana, Public Policy, Uncategorized
In May 2013, I observed spiking THC levels in my young patients and a rapidly growing market in Colorado for foods and drinks infused with the drug, the active ingredient of marijuana that produces a euphoric high. What I saw prompted me to raise concerns about what...
by Christine Tatum | Jan 26, 2015 | Marijuana, Public Policy, Uncategorized
The American Academy of Pediatrics — a professional organization of 62,000 pediatricians committed to optimal physical, mental and social health for children, adolescents and young adults — today reaffirmed its strong stance against marijuana legalization...
by Chris Thurstone | Jun 26, 2014 | Public Policy, Research, Uncategorized
First, please let me be clear: I want more research of Cannabidiol, the nonintoxicating component of the cannabis plant that has shown some medical promise — particularly for the treatment of children with intractable epilepsy. I want that research to comply...